Colorectal Cancer Screening in 2026: Who Should Get Tested, Which Options Are Covered, and What the Latest Guidance Means for You

If you are 45 or older and at average risk for colorectal cancer, you should be talking with a clinician about screening. That’s the clear message from current U.S. guidelines. You have more than one effective option, most insurance plans and Medicare cover recommended screening tests, and early detection can prevent cancer or catch it when it is highly treatable.

Here’s what the latest guidance means for adults and families in 2026.

Why colorectal cancer screening matters in 2026

Colorectal cancer is the third most common cancer diagnosed in men and women in the United States. Screening has helped lower rates in older adults, but cases in people under 50 have increased over the past decade. That shift is one reason national experts lowered the starting age for routine screening.

The U.S. Preventive Services Task Force (USPSTF), an independent panel that reviews medical evidence, recommends screening starting at age 45 for adults at average risk. This is a Grade A recommendation, meaning there is high certainty that the net benefit is substantial.

Screening works in two ways: it can find cancer early, when treatment is more likely to succeed, and it can prevent cancer by finding and removing precancerous polyps before they turn into cancer.

Who should be screened — and at what ages

According to the USPSTF:

Ages 45 to 75: Screen all adults at average risk.
Ages 76 to 85: Screening decisions should be individualized based on overall health, prior screening history, and patient preference.

The CDC and the National Cancer Institute (NCI) echo this guidance.

“Average risk” means you do not have:

A personal history of colorectal cancer or certain types of polyps
A strong family history of colorectal cancer
Inflammatory bowel disease (ulcerative colitis or Crohn’s disease involving the colon)
Known hereditary cancer syndromes such as Lynch syndrome or familial adenomatous polyposis (FAP)

If you have any of these risk factors, you may need to start screening earlier and be screened more often. That decision should be made with a gastroenterologist or primary care clinician.

Average risk vs. higher risk: who needs earlier testing?

You may need screening before age 45 if:

A parent, sibling, or child had colorectal cancer, especially before age 60
You have a history of advanced polyps
You have inflammatory bowel disease affecting the colon
You have a known inherited syndrome such as Lynch syndrome

In these cases, colonoscopy is often the preferred test, and screening may begin in your 20s, 30s, or 40s depending on the condition.

Comparing your options: stool tests, colonoscopy, and CT colonography

There is no single “best” test for everyone. The best test is the one you complete on schedule.

1. Stool-based tests (at home)

These tests look for signs of cancer in stool samples.

FIT (fecal immunochemical test): Done every year.
Stool DNA-FIT test: Done every 1 to 3 years, depending on the specific test and guidance.

These tests are noninvasive and done at home. They do not detect or remove polyps directly. They look for hidden blood or abnormal DNA that may signal cancer or advanced polyps.

If a stool test is positive, you must have a follow-up colonoscopy to complete the screening process.

2. Colonoscopy

Colonoscopy is typically done every 10 years if results are normal.

During the procedure, a clinician examines the entire colon using a flexible camera and can remove polyps at the same time. That makes colonoscopy both a detection test and a prevention tool.

It requires bowel preparation the day before and sedation during the procedure. Small risks include bleeding or perforation, but serious complications are uncommon.

3. CT colonography (“virtual colonoscopy”)

This imaging test is usually done every 5 years. It uses CT scans to create detailed images of the colon.

If an abnormality is found, a standard colonoscopy is needed to remove polyps or take biopsies.

The American Cancer Society provides a practical comparison of these options and emphasizes that personal preference, access, and comfort level all matter.

What happens if a test is positive?

If a stool-based test shows an abnormal result, the next step is a colonoscopy. This is not optional. Without follow-up colonoscopy, screening is incomplete.

If colonoscopy finds polyps, they are usually removed and sent for testing. If cancer is found, additional imaging and staging tests help determine treatment options.

A positive stool test does not automatically mean cancer. Many abnormal stool tests are due to noncancerous polyps or other causes of bleeding. That is why follow-up testing is essential.

What insurance and Medicare cover — and when costs may apply

Because colorectal cancer screening for ages 45 to 75 carries a USPSTF Grade A recommendation, most private insurance plans must cover recommended screening tests without cost-sharing when performed in-network. This requirement comes from the Affordable Care Act, as explained by HealthCare.gov.

Medicare also covers colorectal cancer screening. According to Medicare.gov:

Screening colonoscopy is covered at specified intervals.
Stool-based tests such as FIT are covered at recommended intervals.

However, there are important details:

Coverage depends on plan type and in-network providers.
If a colonoscopy is performed because of symptoms (such as bleeding), it may be considered diagnostic rather than screening and could involve cost-sharing.
If a screening colonoscopy leads to polyp removal, coverage rules may vary by plan, although recent policy changes have reduced cost barriers in many cases.

Before scheduling, it’s wise to call your insurer or check your Medicare plan details to confirm coverage.

Screening vs. diagnostic colonoscopy: why the distinction matters

Screening colonoscopy is done when you have no symptoms and are being tested based on age or risk.

Diagnostic colonoscopy is done to evaluate symptoms such as bleeding, unexplained anemia, or persistent changes in bowel habits.

This distinction can affect how insurance classifies and bills the procedure. If you have symptoms, talk with your clinician and insurer so you understand potential costs.

Barriers, disparities, and practical tips

Screening rates are lower in some communities, including people without regular primary care access and certain racial and ethnic groups. Transportation, time off work, language barriers, and confusion about coverage all play a role.

Practical steps to stay on schedule:

Mark your calendar for annual FIT if you choose stool testing.
Schedule colonoscopy well in advance if you prefer that option.
Ask about mailed stool kits through your health system.
Confirm in-network status before procedures.
Do not ignore abnormal results — follow up promptly.

Bottom line: what this means for you

If you are 45 or older and at average risk, colorectal cancer screening should be part of your preventive health plan.

You have multiple effective options. Stool-based tests are convenient and noninvasive but must be repeated regularly and followed by colonoscopy if positive. Colonoscopy is less frequent and allows immediate polyp removal but requires preparation and a procedure visit.

Most private insurance plans and Medicare cover recommended screening without cost-sharing when used appropriately. Earlier or more frequent screening is needed if you have certain risk factors.

The most important step is starting the conversation. Talk with your clinician about your risk, your preferences, and how to schedule your screening. Early detection saves lives — and in many cases, prevents cancer before it starts.

Sources

This article is for general informational purposes only and is not medical advice. Research findings can be early, limited, or subject to change as new evidence emerges. For personal guidance, diagnosis, or treatment, consult a licensed clinician. For current outbreak or public health guidance, follow your local health department, the CDC, or another relevant public health authority.